Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Income from Continuing Operations (2016 - 2026)

Ani Pharmaceuticals' Income from Continuing Operations history spans 15 years, with the latest figure at 27525000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 367.86% to 27525000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 78361000.0, a 523.07% increase, with the full-year FY2025 number at 78337000.0, up 522.94% from a year prior.
  • Income from Continuing Operations hit 27525000.0 in Q4 2025 for Ani Pharmaceuticals, up from 26600000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for ANIP hit a ceiling of 27525000.0 in Q4 2025 and a floor of 24166000.0 in Q3 2024.
  • Historically, Income from Continuing Operations has averaged 590600.0 across 5 years, with a median of 1088500.0 in 2021.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 18370.0% in 2022 and later skyrocketed 1135.21% in 2024.
  • Tracing ANIP's Income from Continuing Operations over 5 years: stood at 24098000.0 in 2021, then soared by 82.24% to 4280000.0 in 2022, then skyrocketed by 126.99% to 1155000.0 in 2023, then crashed by 989.7% to 10276000.0 in 2024, then surged by 367.86% to 27525000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for ANIP at 27525000.0 in Q4 2025, 26600000.0 in Q3 2025, and 8549000.0 in Q2 2025.